Evidence map›Paper›PMID 24847411›Full record

ArticleThe American journal of case reports2014

Weight change therapy as a potential treatment for end-stage ovarian carcinoma.

Kuat Pernekulovich Oshakbayev, Kenneth Alibek, Igor Olegovich Ponomarev, Nurlybek Nurlanovich Uderbayev, Bibazhar Abayevna Dukenbayeva

Open access · hybridAbstract read
In one paragraph

Article in The American journal of case reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Metabolic risk factors of ovarian cancer: a review.JBRA assisted reproduction · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. HOTAIR Interacting with MAPK1 Regulates Ovarian Cancer skov3 Cell Proliferation, Migration, and Invasion.Medical science monitor : international medical journal of experimental and clinical research · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kuat Pernekulovich OshakbayevDepartment of Oncology, Republican Scientific Center for Emergency Medicine, Astana, Republic of Kazakhstan.
Kenneth AlibekDepartment of Oncology, Republican Scientific Center for Emergency Medicine, Astana, Republic of Kazakhstan.
Igor Olegovich PonomarevDepartment of Oncology, Republican Scientific Center for Emergency Medicine, Astana, Republic of Kazakhstan.
Nurlybek Nurlanovich UderbayevDepartment of Surgery, Republican Scientific Center for Emergency Care, Astana, Republic of Kazakhstan.
Bibazhar Abayevna DukenbayevaDepartment of Pathology, Astana Medical University, Astana, Republic of Kazakhstan.
Republican Center for Healthcare Development · KZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

patientFemale, 41 FINAL DIAGNOSIS: Ovarian carcinoma Symptoms: Ascites • hepatomegaly • weight loss MEDICATION: - Clinical Procedure: - Specialty: Oncology.

objectiveUnusual or unexpected effect of treatment.

backgroundThe aim of this case report is to present the results of treatment of end-stage ovarian carcinoma in a 41-year-old women using weight loss therapy. CASE REPORT: We describe the case of a female aged 41 years with epithelial invasive ovarian cancer of III-IV stage, T3N2M1. Concurrent diseases were: abdominal carcinomatosis; hepatomegaly; ascites; condition after laparocentesis and skin-abdominal fistula; condition after 6 courses of neo-adjuvant polychemotherapy; hypertension II stage, risk factor of 3-4; dyslipidemia; and metabolic syndrome. A weight loss method based on a very-low-calorie diet and physical activity was used. Body weight was reduced from 74 kg to 53 due to loss of adipose tissue after 6 months of therapy. At the same time, the percentages of water and muscle tissue were increased significantly. While overweight was reducing, clinical, laboratory, and instrumental results were improving. As a result of the weight loss therapy, about ≈100 mm-sized ovarian cancer was transformed into smaller-sized ovarian cysts.

conclusionsAn analgesic effect was also achieved without use of narcotic or non-narcotic analgesics. These cyto-reversible processes were documented by laboratory and instrumental data. The mechanisms behind these differences remain to be elucidated. Future research with a larger study cohort and longer follow-up is needed to further investigate the role of caloric restriction diet in cancer cell changes in ovarian cancer.

Indexed as

Metabolic Syndrome XOvarian NeoplasmsWeight Loss

Identifiers

PMID24847411
PMCPMC4025513
OpenAlexW2143792540

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.